Literature DB >> 22884716

The RSV fusion receptor: not what everyone expected it to be.

Peter Mastrangelo1, Richard G Hegele.   

Abstract

This article reviews current knowledge about respiratory syncytial virus (RSV) binding and entry into cells. The recent discovery of Nucleolin as a fusion receptor for RSV opens new avenues for developing interventions, while raising questions concerning RSV pathobiology and tropism. We also discuss characteristics of a good RSV drug target.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22884716     DOI： 10.1016/j.micinf.2012.07.015

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  5 in total

1.  Inhibition of Respiratory Syncytial Virus Infection by Small Non-Coding RNA Fragments.

Authors:  Sandra Axberg Pålsson; Vaishnovi Sekar; Claudia Kutter; Marc R Friedländer; Anna-Lena Spetz
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

2.  Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus.

Authors:  Chompunuch Boonarkart; Ornpreya Suptawiwat; Kanyarat Ruangrung; Kittipong Maneechotesuwan; Prasert Auewarakul
Journal:  Arch Virol       Date:  2021-06-25       Impact factor: 2.574

3.  M1-like, but not M0- or M2-like, macrophages, reduce RSV infection of primary bronchial epithelial cells in a media-dependent fashion.

Authors:  Natalie J Ronaghan; Mandy Soo; Uriel Pena; Marisa Tellis; Wenming Duan; Nooshin Tabatabaei-Zavareh; Philipp Kramer; Juan Hou; Theo J Moraes
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

4.  Characterization of an experimental vaccine for bovine respiratory syncytial virus.

Authors:  Sara Hägglund; Kefei Hu; Krister Blodörn; Boby Makabi-Panzu; Anne-Laure Gaillard; Karin Ellencrona; Didier Chevret; Lars Hellman; Karin Lövgren Bengtsson; Sabine Riffault; Geraldine Taylor; Jean François Valarcher; Jean-François Eléouët
Journal:  Clin Vaccine Immunol       Date:  2014-05-14

5.  Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.

Authors:  Manuel Mata; Isidoro Martinez; Jose A Melero; Herman Tenor; Julio Cortijo
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.